The PI3K/AKT signaling pathway also frequently undergoes genetic alterations in ccRCC which include PTEN deletions or mutations, mTOR mutations, and PIK3CA amplifications or mutations. This evidence concerns the gene PIK3CA and nonpapillary renal cell carcinoma.